PDF下载 ( 1150 KB)
The relationship between of hematopoietic stem cells and hepatitis B virus infection
-
摘要: 目的研究乙型肝炎患者骨髓造血干细胞中HBV的感染、复制及对造血干细胞增殖的影响。方法收集乙型肝炎患者9例,健康者7例骨髓液,磁珠分离仪分离纯化骨髓液CD34+细胞,取部分干细胞进行免疫组化和原位杂交,以感染HBV的干细胞（2.2.15细胞）为阳性对照,并设健康人骨髓干细胞为阴性对照。余两组干细胞分别分为两组,一组在含有干细胞生长因子（SCF）、酪氨酸激酶受体家族Ⅲ的配体（FLT3）、促血小板生成素（TPO）、白介素-3（IL-3）和10%FBS的IMDM培养基中孵育,另一组在无细胞因子的同样培养基中孵育。第0、1、6、12d进行PCR病毒载量检测并做细胞计数。结果患者组骨髓干细胞经免疫组化染色后为变为棕黄色与阳性对照组一致,经原位杂交后细胞染色为蓝紫色与阳性对照组一致,而阴性对照组均未染色。对患者组骨髓干细胞加细胞因子和无细胞因子第1、6、12d细胞计数分别比较,均明显少于正常对照组（t=0.818,P<0.05;t=3.599,P<0.05;t=2.967,P<0.05）。加细胞因子患者组第6、12d细胞内病毒载量明显高于不加细胞因子患者组（t=3.36,P<...Abstract: Objective To investigate the impact of HBV infection on the bone marrow haematopoietic stem cell (HSC) .Methods Nine hepatitis B patients and 7 healthy donors were included in this study.Bone marrow samples were collected and the CD34+ cells were purified by mini-MACS.HSCs were studied by immunohistochemiststy and hybridization in situ.HepG2.21 and HSC of healthy donors were used as a positive and negative control, respectively.HSCs were incubated with or without cytokine markers (SCF, FLT3, TPO, IL-3) .HBVDNA was detected by PCR and cells were counted on day 0, 1, 6 and 12 day.Results The immunohistochemistry result of HSCs in HBV patients showed blue-purple color among positive controls compared to healthy control group.The number of HSCs in the patient group was less than healthy control group on day 1, 6 and 12 after incubation with or without cytokines (t=0.818, P<0.05;t=3.599, P<0.05;t=2.967, P<0.05) .HBVDNA was higher after incubation with cytokine in the patient group than healthy control group on day 6 and 12 (t=3.36, P<0.05;t=5.71, P<0.01) .Conclusion HBV infects and replicate in bone marrow inhibiting the proliferation ability of HSCs.
-
Key words:
- hemotopoietic stem cells /
- hepatitis B /
- hepatitis B virus
-
[1]Pontisso P, Vidalino L, Quarta S, et al.Biological and clinical im-plications of HBV infection in peripheral blood mononuclearcells[J].Autoimmun Rev, 2008, 8 (1) ∶13-17. [2]Lianq R.How I treat and monitor viral hepatitis B infection in pa-tients receiving intensive immunosuppressive therapies or undergoinghematopoietic stem cell[J].Blood, 2009, 113 (14) ∶3147-3153. [3]Cariani E, Pelizzari AM, Rodella A, et al.Immune-mediated hep-atitis-associated aplastic anemia caused by the emergence of a mu-tant hepatitis B virus undetectable by standard assays[J].Hepatol, 2007, 46 (4) ∶743-747. [4] 中华医学会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) ∶3-15. [5]Kimua T, Minamiguchi H, Wang J, et al.Impaired stem cell functionof CD34+cell selected by tow different imminomagnectic beads sys-tems[J].Leukemia, 2004, 18 (3) ∶566-574. [6]Ali BA, Huang TH, SalemHH, et al.Salem.Expression of hepatitisB virus genes in early embryonic cells originated from hamster ovaand human spermatozoa transfected with the complete viralgenome[J].Asian J Androl, 2006, 8 (3) ∶273-279. [7]Weissman IL.Stem cell:unit of development, unit of regeneration, and units in evolution[J].Cell, 2000, 100 (1) ∶157-168. [8]Spaggiari GM, Abdelrazik H, Becchetti F, et al.Mesenchymal stemcells (MSC) inhibit monocyte-derived dendritic cell (DC) matura-tion and function by selectively interfering with the generation of im-mature DCs:central role of MSC-derived prostaglandin E2[J].Blood, 2009, 113 (26) ∶6576-6583. [9]Vildózola Gonzales H, Salinas JL, et al.Natural history of chronichepatitis B virus infection[J].Rev Gastroenterol Peru, 2009, 29 (2) ∶147-157. -
本文二维码
计量
- 文章访问数: 2405
- HTML全文浏览量: 17
- PDF下载量: 709
- 被引次数: 0
下载:
